INSRMi020-A

PC130k2c

General

Cell Line

hPSCreg name INSRMi020-A
Cite as:
INSRMi020-A
Alternative name(s)
PC130k2c
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines
INSRMi019-A
(PC129K8)
Donor diseases:
myofibrillar myopathy 1
INSRMi012-C
(PC173T19)
Donor diseases:
myofibrillar myopathy 1
INSRMi013-A
(PC179c1)
Donor diseases:
myofibrillar myopathy 1
INSRMi021-A
(PC177 3c14)
Donor diseases:
myofibrillar myopathy 1
ITXi013-A
(PT-R406W)
Donor's gene variants:
DES
Donor diseases:
Desminopathy
ITXi013-B
(IC-R406)
Donor's gene variants:
DES
Donor diseases:
Desminopathy
FAMRCi002-A
(OBC7)
Donor diseases:
Desminopathy
MRIi027-A
(DMD 01)
Donor diseases:
Duchenne muscular dystrophy
CUIMCi005-A
(BB#2, BB9068#2)
Donor diseases:
Stargardt Disease
FJMUUHi001-A
Donor's gene variants:
PARK7
Donor diseases:
Parkinson's disease 7
SCTCi014-A
(IPS17-00056)
Donor diseases:
Age-Related Macular Degeneration
BIHi002-A
Donor's gene variants:
CLCN7, CLCN7
Donor diseases:
autosomal recessive osteopetrosis 4
SCTCi012-A
(IPS19-00027)
Donor diseases:
age-related macular degeneration
IGIBi001-A
(SCP28)
Donor diseases:
Sickle cell anemia
SCTCi013-A
(IPS19-00053)
Donor diseases:
age-related macular degeneration
USFi001-A
(1CN1.5)
Donor diseases:
Friedreich Ataxia
CMCi002-A
(CMC-GIT-001)
Donor diseases:
Gitelman Syndrome
XMDYYYi001-A
(BDU-iPSCs)
Donor diseases:
Becker muscular dystrophy
HEBHMUi012-A
Donor diseases:
Hypertension
BBANTWi010-A
(iPSC_PBMC_LDS_TGFB3_KE2M_C9)
Donor diseases:
Loeys-Dietz syndrome 5
BCHNi001-A
(BCHi001-A)
Donor diseases:
Bardet-Biedl Syndrome
SHEHi002-A
(iPS36)
Donor's gene variants:
CACNA1C
Donor diseases:
Long QT Syndrome 8
PCIi027-A
(PC086)
Donor diseases:
Waardenburg syndrome
USPi001-A
(iPS_LGH_AHDC1_P1)
Donor's gene variants:
AHDC1
Donor diseases:
Xia-Gibbs Syndrome
IMBAi016-A
(B001-ARID1B#10)
Donor diseases:
Coffin-Siris syndrome
USPi002-A
(iPS_LGH_AHDC1_P2)
Donor's gene variants:
AHDC1
Donor diseases:
Xia-Gibbs Syndrome
USPi003-A
(iPS_LGH_AHDC1_P3)
Donor's gene variants:
AHDC1
Donor diseases:
Xia-Gibbs Syndrome
KMUGMCi006-A
(TS271 #12 WT)
Donor diseases:
Tuberous Sclerosis
KMUGMCi006-B
(TS271 #5 MT)
Donor diseases:
Tuberous Sclerosis
MUBi002-A
(CF 001)
Donor diseases:
Cystic fibrosis
KMUGMCi006-C
(TS271 #21 WT)
Donor diseases:
Tuberous Sclerosis
KMUGMCi006-D
(TS271 #23 WT)
Donor diseases:
Tuberous Sclerosis
KMUGMCi006-E
(TS271 #4 MT)
Donor diseases:
Tuberous Sclerosis
KMUGMCi006-F
(TS271 #20 MT)
Donor diseases:
Tuberous Sclerosis
AIBNi016-A
(SPG2-S376C1)
Donor diseases:
hereditary spastic paraplegia 56
Last update 22nd December 2023
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator INSERM (INSRM)
Owner INSERM (INSRM)
Derivation country France

External Databases

BioSamples SAMEA115046805

General Information

* Is the cell line readily obtainable for third parties?
Yes
Research use: allowed
Clinical use: not allowed
Commercial use: not allowed

Donor Information

General Donor Information

Sex male
Age of donor (at collection) 55-59
Ethnicity unknown

Phenotype and Disease related information (Donor)

Diseases A disease was diagnosed.
Synonyms
  • DES autosomal recessive limb-girdle muscular dystrophy
  • DES myofibrillar myopathy (disease)
  • autosomal recessive limb-girdle muscular dystrophy caused by mutation in DES
  • autosomal recessive limb-girdle muscular dystrophy type 2R
  • desmin-related myofibrillar myopathy
  • desminopathy
  • myofibrillar myopathy (disease) caused by mutation in DES
  • myofibrillar myopathy 1
  • myofibrillar myopathy type 1
  • myopathy, myofibrillar, type 1
  • CMD1F and LGMD1D
  • CMD1F and LGMD1D, formerly
  • IBM1
  • MFM1
  • arrhythmogenic right ventricular cardiomyopathy 7
  • arrhythmogenic right ventricular cardiomyopathy 7, formerly
  • arrhythmogenic right ventricular dysplasia, familial, 7
  • arrhythmogenic right ventricular dysplasia, familial, 7, formerly
  • cardiomyopathy, dilated, 1F and limb-girdle muscular dystrophy type 1D
  • cardiomyopathy, dilated, 1F and limb-girdle muscular dystrophy type 1D, formerly
  • cardiomyopathy, dilated, with conduction defect and muscular dystrophy
  • desmin-related myopathy
  • desmin-related myopathy with arrhythmogenic right ventricular cardiomyopathy
  • desminopathy, primary
  • inclusion body myopathy 1, autosomal dominant
  • inclusion body myopathy 1, autosomal dominant, formerly
  • myofibrillar myopathy with arrhythmogenic right ventricular cardiomyopathy
  • myopathy, myofibrillar, 1
  • myopathy, myofibrillar, desmin-related
show more synonyms
Disease associated phenotypes
  • Cardiomyopathy
Family history Unknown
Is the medical history available upon request? No
Is clinical information available? No

Karyotyping (Donor)

Has the donor karyotype been analysed?
No

Other Genotyping (Donor)

Is there genome-wide genotyping or functional data available?
No

External Databases (Donor)

BioSamples SAMEA115046806

Ethics

Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? Yes
Was the consent voluntarily given? Yes
Has the donor been informed that participation will not directly influence their personal treatment? Yes
Can you provide us with a copy of the Donor Information Sheet provided to the donor? No
Please provide contact information of the holder of the original Donor Information Sheet. See the donor consent form as both documents are merged
Do you (Depositor/Provider) hold the original Donor Consent Form? No
If you do not hold the Donor Consent Form, do you know who does? Yes
Please provide the contact information Phenocell
Alternatives to consent are available? No
Is there other documentation provided to the donor for consenting purposes? No
Confirm that consent was obtained by a qualified professional Yes
Has the donor agreed to be re-contacted? Unknown
Has the donor been informed about how her/his data will be protected? Yes
Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. anonymised
Does consent explicitly allow the derivation of pluripotent stem cells? Yes
Does consent expressly prevent the derivation of pluripotent stem cells? No
Does consent pertain to a specific research project? No
Does consent permit unforeseen future research, without further consent? Yes
Does the consent permit uses of donated embryo/tissue or derived cell line intended for clinical treatment or human applications? Yes
Does consent expressly prevent development of commercial products? No
Does consent expressly prevent financial gain from any use of the donated embryo/tissue, including any product made from it? No
Does consent expressly permit storage of donated embryo/tissue for an unlimited time? Yes
Does consent expressly permit storage of cells derived from the donated embryo/tissue for an unlimited time? Yes
Does consent prevent the DONATED BIOSAMPLE from being made available to researchers anywhere in the world? No
Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? No

Does consent permit research by

an academic institution? Yes
a public organisation? Yes
a non-profit company? Yes
a for-profit corporation? Yes
Does consent expressly permit collection of genetic information? Yes
Does consent expressly permit storage of genetic information? Yes
Does consent prevent dissemination of genetic information? No
Has the donor been informed that their donated biosample or derived cells may be tested for the presence of microbiological agents / pathogens? Yes
Has the donor consented to receive information discovered during use of donated embryo/tissue that has significant health implications for the donor? Yes
How may genetic information associated with the cell line be accessed? Controlled Access
Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? No
Does the consent anticipate that the donor will be notified of results or outcomes of any research involving the donated samples or derived cells? Yes
Does the consent permit the donor, upon withdrawal of consent, to stop the use of the derived cell line(s) that have already been created from donated samples? Yes
Does the consent permit the donor, upon withdrawal of consent, to stop delivery or use of information and data about the donor? Yes
Does consent permit access to medical records of the donor? No
Does consent permit access to any other source of information about the clinical treatment or health of the donor? No
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? Yes
Name of accrediting authority involved? French Ministry for Research, Higher Education and Innovation
Approval number AC-2013-1973, AC-2019-3388
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the PROPOSED PROJECT, involving use of donated embryo/tissue or derived cells? No
Do you have obligations to third parties in regard to the use of the cell line? No
Are you aware of any further constraints on the use of the donated embryo/tissue or derived cells? No
Is there an MTA available for the cell line? No
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used?
Are you aware of any constraints on the use or distribution of the cell line from the owner or any parties identified in the query above? No

hIPSC Derivation

General

Source cell type
A peripheral blood cell with a single nucleus. This category includes lymphocytes and monocytes.
Synonyms
  • PERIPHERAL BLOOD MONONUCLEAR CELL
  • Peripheral Blood Mononuclear Cell
  • PBMC
Source cell origin
A liquid tissue; its major function is to transport oxygen throughout the body. It also supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection. Several hormones also travel in the blood.
Synonyms
  • Reticuloendothelial System, Blood
  • Peripheral Blood
  • peripheral blood
  • blood
  • Blood
  • Whole Blood
  • BLOOD
  • portion of blood
  • vertebrate blood
show more synonyms
Age of donor (at collection) 55-59
Collected in 2017

Reprogramming method

Vector type Non-integrating
Vector Sendai virus
Is reprogramming vector detectable?
No
Methods used
PCR

Vector free reprogramming

Other

Selection criteria for clones Morphology of the colony
Derived under xeno-free conditions
No
Derived under GMP?
No
Available as clinical grade?
No

Culture Conditions

Surface coating Matrigel/Geltrex
Feeder cells
No
Passage method Enzyme-free cell dissociation
ReLeSR
O2 Concentration 20 %
CO2 Concentration 5 %
Medium mTeSR™ Plus
Has Rock inhibitor (Y27632) been used at passage previously with this cell line?
No
Has Rock inhibitor (Y27632) been used at cryo previously with this cell line?
No
Has Rock inhibitor (Y27632) been used at thaw previously with this cell line?
Yes

Characterisation

Analysis of Undifferentiated Cells
Marker Expressed Immunostaining RT-PCR Flow Cytometry Enzymatic Assay Expression Profiles
NANOG
Yes
TRA 1-81
Yes
Differentiation Potency
Endoderm
Ont Id: UBERON_0000925
In vitro directed differentiation
Mesoderm
Ont Id: UBERON_0000926
In vitro directed differentiation
Ectoderm
Ont Id: UBERON_0000924
In vitro directed differentiation

Genotyping

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
Yes
46,XX
Passage number: 20
Karyotyping method: G-Banding

Other Genotyping (Cell Line)